{"id":"https://openalex.org/W3192554530","doi":"https://doi.org/10.1016/j.annonc.2021.05.180","title":"P-125 Caring for more than survival: A survey of patient preferences in advanced hepatocellular carcinoma","display_name":"P-125 Caring for more than survival: A survey of patient preferences in advanced hepatocellular carcinoma","publication_year":2021,"publication_date":"2021-07-01","ids":{"openalex":"https://openalex.org/W3192554530","doi":"https://doi.org/10.1016/j.annonc.2021.05.180","mag":"3192554530"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2021.05.180","doi":"https://doi.org/10.1016/j.annonc.2021.05.180","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.05.180","pdf_url":"http://www.annalsofoncology.org/article/S0923753421013697/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.annalsofoncology.org/article/S0923753421013697/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007167001","display_name":"Rohini Sharma","orcid":"https://orcid.org/0000-0003-2441-549X","observed_orcids":["https://orcid.org/0000-0003-2441-549X"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R. Sharma","raw_affiliation_strings":["Department of Surgery and Cancer, Imperial College London, London, W12 0NN, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery and Cancer, Imperial College London, London, W12 0NN, United Kingdom","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062326280","display_name":"Siu Hing Lo","orcid":"https://orcid.org/0000-0002-2952-150X","observed_orcids":["https://orcid.org/0000-0002-2952-150X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Lo","raw_affiliation_strings":["Acaster Lloyd Consulting Ltd., Bloomsbury, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acaster Lloyd Consulting Ltd., Bloomsbury, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043316267","display_name":"Daniel Aggio","orcid":"https://orcid.org/0000-0001-6752-0180","observed_orcids":["https://orcid.org/0000-0001-6752-0180"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Aggio","raw_affiliation_strings":["Acaster Lloyd Consulting Ltd., Bloomsbury, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acaster Lloyd Consulting Ltd., Bloomsbury, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049835130","display_name":"Fabien Colaone","orcid":"https://orcid.org/0000-0002-9171-7861","observed_orcids":["https://orcid.org/0000-0002-9171-7861","https://orcid.org/0009-0000-4372-3792"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Colaone","raw_affiliation_strings":["Sirtex Medical UK Ltd., London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sirtex Medical UK Ltd., London, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014187022","display_name":"Ion Agirrezabal","orcid":"https://orcid.org/0000-0003-3170-7845","observed_orcids":["https://orcid.org/0000-0003-3170-7845"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. Agirrezabal","raw_affiliation_strings":["Sirtex Medical UK Ltd., London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sirtex Medical UK Ltd., London, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053555080","display_name":"Vincenzo A Straccia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Straccia","raw_affiliation_strings":["Sirtex Medical UK Ltd., London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sirtex Medical UK Ltd., London, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072734641","display_name":"Victoria K. Brennan","orcid":"https://orcid.org/0000-0001-7814-2306","observed_orcids":["https://orcid.org/0000-0001-7814-2306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Brennan","raw_affiliation_strings":["Sirtex Medical UK Ltd., London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sirtex Medical UK Ltd., London, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020057997","display_name":"Suki Shergill","orcid":"https://orcid.org/0000-0001-5319-6770","observed_orcids":["https://orcid.org/0000-0001-5319-6770"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Shergill","raw_affiliation_strings":["Sirtex Medical UK Ltd., London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sirtex Medical UK Ltd., London, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004666844","display_name":"AJ Lloyd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Lloyd","raw_affiliation_strings":["Acaster Lloyd Consulting Ltd., Bloomsbury, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acaster Lloyd Consulting Ltd., Bloomsbury, United Kingdom","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015037000","display_name":"Charlotte E. Costentin","orcid":"https://orcid.org/0000-0001-6115-8512","observed_orcids":["https://orcid.org/0000-0001-6115-8512"]},"institutions":[{"id":"https://openalex.org/I2800555055","display_name":"Centre Hospitalier Universitaire de Grenoble","ror":"https://ror.org/041rhpw39","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I2800555055"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Costentin","raw_affiliation_strings":["Hepatology, gastro-enterology and digestive oncology, Grenoble Alpes University Hospital, Grenoble, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hepatology, gastro-enterology and digestive oncology, Grenoble Alpes University Hospital, Grenoble, France","institution_ids":["https://openalex.org/I2800555055"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":null,"first_page":"S141","last_page":"S141"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.009200000204145908,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10841","display_name":"Economic and Environmental Valuation","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-hepatocellular-carcinoma","display_name":"advanced hepatocellular carcinoma","score":0.9089999794960022},{"id":"https://openalex.org/keywords/patient-preferences","display_name":"patient preferences","score":0.9900000095367432},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.8080000281333923},{"id":"https://openalex.org/keywords/treatment-characteristics","display_name":"treatment characteristics","score":0.35600000619888306},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9049999713897705},{"id":"https://openalex.org/keywords/lenvatinib","display_name":"lenvatinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/atezolizumab-plus-bevacizumab","display_name":"atezolizumab plus bevacizumab","score":0.9169999957084656},{"id":"https://openalex.org/keywords/radioembolization","display_name":"radioembolization","score":0.9430000185966492},{"id":"https://openalex.org/keywords/locoregional-therapy","display_name":"locoregional therapy","score":0.8889999985694885},{"id":"https://openalex.org/keywords/systemic-treatment","display_name":"systemic therapy","score":0.6129999756813049},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7739999890327454}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9430774450302124},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5819790959358215},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5728929042816162},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.5671199560165405},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5342743992805481},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.5252532362937927},{"id":"https://openalex.org/C2776264508","wikidata":"https://www.wikidata.org/wiki/Q6523413","display_name":"Lenvatinib","level":4,"score":0.4714188277721405},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47031083703041077},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.4582360088825226},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.42948102951049805},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.19045418500900269}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2021.05.180","doi":"https://doi.org/10.1016/j.annonc.2021.05.180","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.05.180","pdf_url":"http://www.annalsofoncology.org/article/S0923753421013697/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2021.05.180","doi":"https://doi.org/10.1016/j.annonc.2021.05.180","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.05.180","pdf_url":"http://www.annalsofoncology.org/article/S0923753421013697/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320318124","display_name":"Tokyo Cooperative Oncology Group","ror":"https://ror.org/00rbsap34"},{"id":"https://openalex.org/F4320328455","display_name":"Ipsen","ror":"https://ror.org/00d801g55"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3192554530.pdf","grobid_xml":"https://content.openalex.org/works/W3192554530.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4283772058","https://openalex.org/W3184564649","https://openalex.org/W2943780807","https://openalex.org/W4322502445","https://openalex.org/W3201274719","https://openalex.org/W2553341606","https://openalex.org/W4411224594","https://openalex.org/W7154741826","https://openalex.org/W2103392315","https://openalex.org/W2052456753"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2021-08-16T00:00:00"}